$BioAtla (BCAB.US)$ It seems there will be a reverse stock split. Does anyone know the final compliance deadline?

$Robo.ai (AIIO.US)$The bears are almost done, it's time for the bulls to take action

$BioAtla (BCAB.US)$ It's dropped quite a bit, leaving all holders trapped. Let's see if it dares to fall to $0.20.

$Dragonfly Energy (DFLI.US)$ No wonder this company's stock price has fallen so low, continuously issuing new shares to dilute value—reckless actions inevitably lead to failure.

$VYNE Therapeutics (VYNE.US)$ 1-1.3 is expected.

$Applied Therapeutics (APLT.US)$ Let me share my personal perspective. As a buyer, if I intend to acquire this R&D company, it must be because I see the promising development prospects of its products. At this point, it would make sense to first release some negative news to depress the stock price so that the acquisition can be completed at the lowest possible cost for maximum effect. Moreover, the plan is to purchase the entire R&D team as a package deal. The stock price is unlikely to fall below 0.088 yuan (the buyer's price), and the buyer has already achieved this, now awaiting approval. Once the acquisition is finalized, various positive developments will be announced to drive up the stock price, ensuring a perfect acquisition. From another perspective, retail investors should recognize that all the company’s R&D projects remain unchanged; only the ownership has shifted to a wealthier investor, which is undoubtedly beneficial for the R&D team. The current stock price is not much higher than what the new owner paid. I understand the hesitation to add more shares, but those considering selling at a loss should think carefully before acting, as they might be selling at the bottom. This is my personal opinion, and I hope it can provide some guidance to newcomers.

$Incannex Healthcare (IXHL.US)$ Take a look at the stocks recently purchased by the CEO.

$Incannex Healthcare (IXHL.US)$The daily and weekly charts both look promising, with today's long lower shadow serving as a bullish breakout signal. Additionally, recent share purchases by major shareholders indicate there is no turning back now. A reverse stock split is even less likely; the only path forward is upward.It won't be long before the price firmly rises above $1, which has already become the minimum standard.

$Amber International Holding (AMBR.US)$ It is very likely to be the brightest star tonight, primarily due to earnings growth and the company’s commitment to repurchase $50 million worth of shares. Both are solid indicators. After the market opens and pulls back, one can consider buying at a lower price to see how high it can go tonight. However, there is significant overhead resistance, and once those investors break even, they are likely to immediately turn into sellers. Expectations should not be set too high.

$BioAtla (BCAB.US)$ Today, everyone can watch the performance as the bears are attempting to drive down the market while the bulls must defend it to ensure that the closing price remains above one dollar. In recent days, those defending the market have been keeping a closer watch than even us.